0.9046
price down icon1.40%   -0.0139
 
loading
전일 마감가:
$0.9185
열려 있는:
$0.9138
하루 거래량:
1.90M
Relative Volume:
0.53
시가총액:
$273.29M
수익:
-
순이익/손실:
$-63.08M
주가수익비율:
-2.4449
EPS:
-0.37
순현금흐름:
$-72.53M
1주 성능:
-9.44%
1개월 성능:
-3.50%
6개월 성능:
-51.05%
1년 성능:
+134.01%
1일 변동 폭
Value
$0.891
$0.9381
1주일 범위
Value
$0.8534
$1.02
52주 변동 폭
Value
$0.36
$2.105

오큐젠 Stock (OCGN) Company Profile

Name
명칭
Ocugen Inc
Name
전화
484-328-4701
Name
주소
11 GREAT VALLEY PARKWAY, MALVERN, PA
Name
직원
84
Name
트위터
@Ocugen
Name
다음 수익 날짜
2024-11-08
Name
최신 SEC 제출 서류
Name
OCGN's Discussions on Twitter

OCGN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
OCGN 0.9047 273.29M 0 -63.08M -72.53M -0.37
VRTX 448.45 115.43B 10.63B -479.80M -1.35B 13.33
REGN 747.78 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 587.26 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 247.71 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 106.50 24.89B 3.30B -501.07M 1.03B 11.54

오큐젠 Stock (OCGN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-10-15 개시 Maxim Group Buy
2023-03-01 업그레이드 Chardan Capital Markets Neutral → Buy
2022-08-23 개시 Mizuho Buy
2022-06-15 재개 ROTH Capital Buy
2022-06-02 개시 Cantor Fitzgerald Overweight
2021-07-26 개시 Noble Capital Markets Outperform
2021-06-11 다운그레이드 ROTH Capital Buy → Neutral
2021-05-07 다운그레이드 Cantor Fitzgerald Overweight → Neutral
2021-02-09 다운그레이드 Chardan Capital Markets Buy → Neutral
2021-02-04 업그레이드 H.C. Wainwright Neutral → Buy
모두보기

오큐젠 주식(OCGN)의 최신 뉴스

pulisher
01:55 AM

Ocugen Announces European Medicines Agency Grants Orphan - GlobeNewswire

01:55 AM
pulisher
Nov 20, 2024

Ocugen reports positive data for OCU400, OCU410 - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Ocugen Inc. stock rises Wednesday, outperforms market - MarketWatch

Nov 20, 2024
pulisher
Nov 20, 2024

Ocugen announces EMA granted orphan medicinal product designation for OCU410ST - TipRanks

Nov 20, 2024
pulisher
Nov 20, 2024

Ocugen Advances Gene Therapy and Financial Strategies in Q3 2024 - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Ocugen's Eye Disease Drug Shows 84% Lesion Reduction, Receives EMA Orphan Status | OCGN Stock News - StockTitan

Nov 20, 2024
pulisher
Nov 19, 2024

Ocugen Inc. stock falls Tuesday, underperforms market - MarketWatch

Nov 19, 2024
pulisher
Nov 19, 2024

Ocugen announces positive preliminary data from OCU410 Phase 1 clinical trial for geographic atrophy - Ophthalmology Times

Nov 19, 2024
pulisher
Nov 19, 2024

Ocugen announces preliminary efficacy, safety data from Phase 1/2 OCU410 trial - TipRanks

Nov 19, 2024
pulisher
Nov 19, 2024

Ocugen Announces Compelling Preliminary Data for OCU410—a Single Dose Novel Modifier Gene Therapy to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration - Ocugen

Nov 19, 2024
pulisher
Nov 19, 2024

Ocugen Announces Compelling Preliminary Data for OCU410—a - GlobeNewswire

Nov 19, 2024
pulisher
Nov 19, 2024

Ocugen's Eye Treatment Shows 21% Disease Slowdown in Phase 1 Trial Data | OCGN Stock News - StockTitan

Nov 19, 2024
pulisher
Nov 18, 2024

Ocugen Inc. stock falls Monday, underperforms market - MarketWatch

Nov 18, 2024
pulisher
Nov 18, 2024

OCGN Stock: Can New Leadership Save This Biotech Company? - TipRanks

Nov 18, 2024
pulisher
Nov 15, 2024

Ocugen Inc. stock falls Friday, underperforms market - MarketWatch

Nov 15, 2024
pulisher
Nov 15, 2024

Ocugen Appoints Ramesh Ramachandran as Financial Officer - TipRanks

Nov 15, 2024
pulisher
Nov 15, 2024

Dow Jones Transportations Average (DOWT) QuotePress Release - The Globe and Mail

Nov 15, 2024
pulisher
Nov 15, 2024

TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail

Nov 15, 2024
pulisher
Nov 15, 2024

TSX 60 Index (TXSX) QuotePress Release - The Globe and Mail

Nov 15, 2024
pulisher
Nov 15, 2024

Nasdaq Health Care Index (IXHC) QuotePress Release - The Globe and Mail

Nov 15, 2024
pulisher
Nov 15, 2024

TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail

Nov 15, 2024
pulisher
Nov 15, 2024

Microsoft Corp (MSFT-Q) QuotePress Release - The Globe and Mail

Nov 15, 2024
pulisher
Nov 15, 2024

Ocugen: Q3 Earnings Snapshot - New Haven Register

Nov 15, 2024
pulisher
Nov 14, 2024

Ocugen, Inc. (OCGN) Quarterly 10-Q Report - Quartzy

Nov 14, 2024
pulisher
Nov 14, 2024

Ocugen Inc. stock rises Thursday, outperforms market - MarketWatch

Nov 14, 2024
pulisher
Nov 14, 2024

Ocugen (OCGN) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Nov 14, 2024
pulisher
Nov 14, 2024

SEC Form 10-Q filed by Ocugen Inc. - Quantisnow

Nov 14, 2024
pulisher
Nov 14, 2024

HC Wainwright Has Pessimistic View of Ocugen FY2024 Earnings - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

Ocugen Inc. stock falls Wednesday, underperforms market - MarketWatch

Nov 13, 2024
pulisher
Nov 12, 2024

Ocugen to Present Innovations at Nasdaq Clinical Showcase - TipRanks

Nov 12, 2024
pulisher
Nov 11, 2024

Navigating 4 Analyst Ratings For Ocugen - Benzinga

Nov 11, 2024
pulisher
Nov 11, 2024

Ocugen (NASDAQ:OCGN) Given Buy Rating at HC Wainwright - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Chardan Capital Reaffirms Buy Rating for Ocugen (NASDAQ:OCGN) - MarketBeat

Nov 11, 2024
pulisher
Nov 09, 2024

Earnings call: Ocugen outlines progress in ophthalmology trials, financials - Investing.com

Nov 09, 2024
pulisher
Nov 09, 2024

Earnings call: Ocugen outlines progress in ophthalmology trials, financials By Investing.com - Investing.com Australia

Nov 09, 2024
pulisher
Nov 09, 2024

Ocugen, Inc. (NASDAQ:OCGN) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 09, 2024
pulisher
Nov 09, 2024

Ocugen Inc (OCGN) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - Yahoo Finance

Nov 09, 2024
pulisher
Nov 08, 2024

Ocugen: Progress in Gene Therapy and Financial Outlook - TipRanks

Nov 08, 2024
pulisher
Nov 08, 2024

Ocugen (OCGN) Q3 2024 Earnings Call Transcript - The Motley Fool

Nov 08, 2024
pulisher
Nov 08, 2024

OCGN Earnings: Ocugen’s Q3 Results Disappoint - TipRanks

Nov 08, 2024
pulisher
Nov 08, 2024

Ocugen receives $30M credit facility to fund, allocate resources across company - Pennsylvania Business Report

Nov 08, 2024
pulisher
Nov 08, 2024

Ocugen reports Q3 revenue $1.136M, consensus $300,000 - TipRanks

Nov 08, 2024
pulisher
Nov 08, 2024

Ocugen Provides Business Update with Third Quarter 2024 Financial Results - Ocugen

Nov 08, 2024
pulisher
Nov 08, 2024

Ocugen Secures $65M Financing, Extends Runway to 2026 as Gene Therapy Trials Advance | OCGN Stock News - StockTitan

Nov 08, 2024
pulisher
Nov 08, 2024

Ocugen (NASDAQ:OCGN) soars 19% this week, taking one-year gains to 193% - Simply Wall St

Nov 08, 2024
pulisher
Nov 07, 2024

A Preview Of Ocugen's Earnings - Benzinga

Nov 07, 2024
pulisher
Nov 07, 2024

Ocugen Secures $30 Million In Debt Funding - citybiz

Nov 07, 2024
pulisher
Nov 07, 2024

Ocugen Secures $30 Million in Debt Funding - Ocugen

Nov 07, 2024
pulisher
Nov 07, 2024

Ocugen, Inc. Secures $30 Million in Debt Funding - Marketscreener.com

Nov 07, 2024

오큐젠 (OCGN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
자본화:     |  볼륨(24시간):